Sean joined Cytiva in December 2021 as General Manager, Customer Portfolio Strategy. Passionate about scientific advances that enable future medicine development, he is focused on driving specific customer value propositions in Cytiva’s technological response and strengthening long-term partnerships with our key customers. In addition, he is also working on developing deeper relationships with stakeholders in the startup biotech ecosystem.
Before coming to Cytiva, he held the role of Executive Director, Business Analytics and External Innovations at RA Capital Management, a Boston, MA-based life sciences venture and hedge fund. There he led the in-depth understanding of R&D portfolio strategy of large pharma and the commercial assessment of portfolio holdings to enable investment decisions.
Prior to that, Sean held the role of Associate Vice President of Research & External Science Innovations at Allergan with a portfolio of responsibilities including Scientific BD Leader, Biomarkers and Combination Drug Strategy Leader and Research Project Leader.
In 2013, Sean joined Sigma Aldrich group as Director, Global Strategic Marketing & Collaborations for the Research Business after many years at Pfizer in various positions of responsibility in R&D and External Innovation.
Sean fiercely believes that scientific and technological advances can and will positively impact humanity by addressing critical issues in healthcare, education, inequality and poverty.
He earned his in Ph.D. Pharmacology & Toxicology, at Medical College of Wisconsin, Milwaukee, WI and an Executive MBA from Washington University in St Louis, St. Louis, MO. Sean holds a BS in Mathematics from Beloit College, Beloit, WI.